Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JS001 (Toripalimab) + Chemo in Advanced Small Cell Esophageal Carcinoma
NCT05173246Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2020
- Primary completion
- Dec 2025
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of toripalimab in small cell carcinoma of the esophagus (SCEC), sponsored by Sun Yat-sen University. Started Nov 2020; status: recruiting.
02
Drugs
toripalimab
03
Conditions
small cell carcinoma of the esophagus (SCEC)
Beyond the preview
Go deeper on NCT05173246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05173246.